Pharma Mar, S.A. (FRA:PMRA)

Pharma Mar Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	179.28	174.86	158.15	196.34	229.83	269.96
Revenue Growth (YoY)	7.35%	10.56%	-19.45%	-14.57%	-14.87%	214.57%
Cost of Revenue	9.8	8.18	9.61	13.64	16.44	13.72
Gross Profit	169.48	166.67	148.54	182.7	213.39	256.24
Selling, General & Admin	55.31	47.18	41.81	43.24	39.74	35.77
Research & Development	97.12	103.5	99.3	83.45	72.17	53.79
Other Operating Expenses	-4.95	9.52	11.26	13.94	9.04	9.77
Operating Expenses	147.48	160.2	152.37	140.63	120.95	99.6
Operating Income	22	6.47	-3.83	42.07	92.45	156.64
Interest Expense	-4.2	-2.47	-2.42	-2.38	-3.37	-3.12
Interest & Investment Income	4.82	5.68	4.32	0.88	0.37	0.34
Currency Exchange Gain (Loss)	2.31	2.31	-1.68	3.11	5.67	-7.55
EBT Excluding Unusual Items	24.92	11.99	-3.61	43.68	95.12	146.31
Gain (Loss) on Sale of Investments	-	-	-0.02	-1.89	0.01	-0.7
Other Unusual Items	-	-	-	2	-	-
Pretax Income	24.92	11.99	-3.62	43.79	95.13	145.61
Income Tax Expense	-9.09	-14.14	-4.76	-5.57	2.27	8.34
Earnings From Continuing Operations	34.01	26.13	1.14	49.36	92.86	137.26
Net Income to Company	34.01	26.13	1.14	49.36	92.86	137.26
Net Income	34.01	26.13	1.14	49.36	92.86	137.26
Net Income to Common	34.01	26.13	1.14	49.36	92.86	137.26
Net Income Growth	5367.04%	2197.71%	-97.70%	-46.85%	-32.35%	-
Shares Outstanding (Basic)	17	18	18	18	18	18
Shares Outstanding (Diluted)	17	18	18	18	18	18
Shares Change (YoY)	-	-1.98%	-0.81%	-0.12%	-1.31%	-0.77%
EPS (Basic)	1.95	1.49	0.06	2.73	5.14	7.50
EPS (Diluted)	1.95	1.49	0.06	2.73	5.13	7.49
EPS Growth	-	2382.56%	-97.80%	-46.78%	-31.51%	-
Free Cash Flow	16.72	-8.99	-28.25	29.47	17.87	275.94
Free Cash Flow Per Share	0.96	-0.51	-1.58	1.63	0.99	15.06
Dividend Per Share	-	0.800	0.650	0.650	0.650	0.600
Dividend Growth	-	23.08%	-	-	8.33%	25.00%
Gross Margin	94.53%	95.32%	93.92%	93.05%	92.85%	94.92%
Operating Margin	12.27%	3.70%	-2.42%	21.43%	40.22%	58.03%
Profit Margin	18.97%	14.94%	0.72%	25.14%	40.40%	50.84%
Free Cash Flow Margin	9.33%	-5.14%	-17.87%	15.01%	7.78%	102.21%
EBITDA	26.95	10.07	-1.15	44.88	94.99	159.09
EBITDA Margin	15.03%	5.76%	-0.73%	22.86%	41.33%	58.93%
D&A For EBITDA	4.95	3.6	2.68	2.81	2.54	2.45
EBIT	22	6.47	-3.83	42.07	92.45	156.64
EBIT Margin	12.27%	3.70%	-2.42%	21.43%	40.22%	58.03%
Effective Tax Rate	-	-	-	-	2.39%	5.73%
Revenue as Reported	179.28	174.86	158.15	196.34	229.83	269.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.